Natera's Q3 Revenues Drop 3 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Natera reported after the close of the market Thursday that its third quarter 2015 revenues were down 3 percent from its third quarter 2014 revenues.

The San Carlos, California-based molecular diagnostics company brought in total revenue of $44.9 million in the quarter, down from $46.3 million in Q3 2014, but beating Wall Street's average estimate of $43.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.